Article Details

Q32 Bio to Participate in Upcoming March Investor Conferences - Placera

Retrieved on: 2025-02-26 12:01:20

Tags for this article:

Click the tags to see associated articles and topics

Q32 Bio to Participate in Upcoming March Investor Conferences - Placera. View article details on hiswai:

Excerpt

... immune system to re-balance immunity in autoimmune and inflammatory diseases. Q32 Bio is advancing bempikibart (ADX-914), a fully human anti-IL ...

Article found on: www.placera.se

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo